A. Jacquemin-Sablon

发表

Alteration in p53 pathway and defect in apoptosis contribute independently to cisplatin-resistance

E. Ségal-Bendirdjian, L. Mannone, A. Jacquemin-Sablon, 1998, Cell Death and Differentiation.

Molecular characterization of human minichromosomes with centromere from chromosome 1 in human-hamster hybrid cells

A. Jacquemin-Sablon, I. Scheffler, J. Mascarello, 1989, Somatic cell and molecular genetics.

Suramin is an inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells.

S. Lelièvre, A. Jacquemin-Sablon, J. Markovits, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Flow and Image Cytometry

A. Jacquemin-Sablon, Image Cytometry, 1996, NATO ASI Series.

Characterization of promoter elements involved in the down-regulation of topoisomerase IIalpha expression in a drug-resistant cell line.

S. Ng, G. Yiu, D. Saxena, 2004, Gene.

Genistein resistance in human leukaemic CCRF-CEM cells: selection of a diploid cell line with reduced DNA topoisomerase II beta isoform.

A. Bernheim, A. Jacquemin-Sablon, F. Goldwasser, 1995, Biochemical pharmacology.

Cellular resistance to the antitumor DNA topoisomerase II inhibitor S16020-2: importance of the N-[2(Dimethylamino)ethyl]carbamoyl side chain.

A. Jacquemin-Sablon, J. Markovits, J. Saucier, 2000, Molecular pharmacology.

Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblasts with human topoisomerase IIalpha cDNA: selective restoration of the sensitivity to DNA religation inhibitors.

A. Jacquemin-Sablon, J. Markovits, H. Jacquemin-Sablon, 1999, Cancer research.

Role of topoisomerase II beta in the resistance of 9-OH-ellipticine-resistant Chinese hamster fibroblasts to topoisomerase II inhibitors.

A. Jacquemin-Sablon, C. Delaporte, S. Dereuddre, 1997, Cancer research.

Effects of verapamil on the cellular accumulations and toxicity of several antitumor drugs in 9-hydroxy-ellipticine-resistant cells.

A. Jacquemin-Sablon, J. Charcosset, C. Delaporte, 1988, Biochemical pharmacology.

Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II.

A. Jacquemin-Sablon, J. Markovits, J. Le Pecq, 1989, Cancer research.

Binding of the Escherichia coli UvrAB Proteins to the DNA Mono- and Diadducts of cis-[N-2-Amino-N-2-methylamino-2,2,1-bicycloheptane]dichloroplatinum(II) and Cisplatin

A. Jacquemin-Sablon, A. Yeung, J. Jestin, 1995, The Journal of Biological Chemistry.

Cysteine control over glutathione homeostasis in Chinese hamster fibroblasts overexpressing a gamma-glutamylcysteine synthetase activity.

A. Jacquemin-Sablon, B. Vincent, S. Mousset, 1999, European journal of biochemistry.

Mammalian DNA Topoisomerase II Inhibitory Effects of the Tyrosine Kinase Inhibitor Genistein on Updated

A. Jacquemin-Sablon, J. Markovits, A. Larsen, 2006 .

Genistein analogues: effects on epidermal growth factor receptor tyrosine kinase and on stress-activated pathways.

A. Jacquemin-Sablon, A. Croisy, E. Bisagni, 1997, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Inhibition by two lavendustins of the tyrosine kinase activity of pp60F527 in vitro and in intact cells.

A. Jacquemin-Sablon, K. Umezawa, J. Pierre, 1994, European journal of pharmacology.

Inhibition of DNA topoisomerases I and II and induction of apoptosis by erbstatin and tyrphostin derivatives.

A. Levitzki, E. Ségal-Bendirdjian, A. Jacquemin-Sablon, 1994, Biochemical pharmacology.

Activation of the mitogen-activated protein kinase cascade by tyrphostin (RG 50864).

A. Jacquemin-Sablon, J. Pierre, S. Mousset, 1994, Biochemical pharmacology.

Attempts to target antitumor drugs toward opioid receptor-rich mouse tumor cells with enkephalin-ellipticinium conjugates.

B. Roques, A. Jacquemin-Sablon, J. Charcosset, 1989, Cancer research.

Characterization of prmt7α and β isozymes from Chinese hamster cells sensitive and resistant to topoisomerase II inhibitors

J. Bujnicki, A. Jacquemin-Sablon, B. Vincent, 2006 .

Characterization of single-copy probe from vicinity of centromere of human chromosome 1

A. Jacquemin-Sablon, I. Scheffler, K. Carine, 1988, Somatic cell and molecular genetics.

Effects of new antitumor bifunctional intercalators derived from 7H-pyridocarbazole on sensitive and resistant L 1210 cells.

B. Roques, A. Jacquemin-Sablon, J. Le Pecq, 1984, Cancer research.

Uptake and cytofluorescence localization of ellipticine derivatives in sensitive and resistant Chinese hamster lung cells.

A. Jacquemin-Sablon, J. Charcosset, B. Salles, 1983, Biochemical pharmacology.

Epidermal growth factor receptor signaling cascade as target for tyrphostin (RG 50864) in epithelial cells. Paradoxical effects on mitogen-activated protein kinase kinase and mitogen-activated protein kinase activities.

A. Jacquemin-Sablon, J. Pierre, F. Nowak, 1997, Biochemical pharmacology.

Nuclear translocation of a leukocyte elastase Inhibitor/Elastase complex during staurosporine-induced apoptosis: role in the generation of nuclear L-DNase II activity.

Y. Courtois, E. Ségal-Bendirdjian, A. Jacquemin-Sablon, 2000, Experimental cell research.

Analysis of the interruptions in bacteriophage T5 DNA.

A. Jacquemin-Sablon, C. Richardson, 1970, Journal of molecular biology.

S16020-2, a new highly cytotoxic antitumor olivacine derivative: DNA interaction and DNA topoisomerase II inhibition.

A. Jacquemin-Sablon, J. Markovits, A. Pierré, 1998, Molecular pharmacology.

Synthesis and binding properties to DNA and to opioid receptors of enkephalin-ellipticinium conjugates.

B. Roques, A. Jacquemin-Sablon, J. Le Pecq, 2009, International journal of peptide and protein research.

Effect of proteolysis on the yeast mitochondrial deoxyribonucleases

A. Jacquemin-Sablon, H. Jacquemin-Sablon, 1984 .

Yeast mitochondrial deoxyribonuclease stimulated by ethidium bromide. 1. Purification and properties.

A. Jacquemin-Sablon, C. Paoletti, H. Jacquemin-Sablon, 1979, Biochemistry.

DNA filter retention assay for exonuclease activities. Application to the analysis of processivity of phage T5 induced 5'-exonuclease.

A. Jacquemin-Sablon, M. Joannes, J. Saucier, 1985, Biochemistry.

Lambda-repressed mutants of bacteriophage T5. II. Physiological characterization.

A. Jacquemin-Sablon, 1979, Journal of molecular biology.

Reduced formation of protein-associated DNA strand breaks in Chinese hamster cells resistant to topoisomerase II inhibitors.

K. Kohn, Y. Pommier, L. Zwelling, 1986, Cancer research.

Isolation and properties of Chinese hamster lung cells resistant to ellipticine derivatives.

A. Jacquemin-Sablon, J. Charcosset, B. Salles, 1982, Cancer treatment reports.

Reduced DNA topoisomerase II activity and drug-stimulated DNA cleavage in 9-hydroxyellipticine resistant cells.

A. Jacquemin-Sablon, J. Charcosset, J. Saucier, 1988, Biochemical pharmacology.

Synthesis of N‐(9H‐Xanthen‐9‐yl)aminoalkanamide and N‐(9H‐Thioxanthen‐9‐yl)aminoalkanamide Derivatives and their in vitro Evaluation as Potential Intercalators and Antitumor Drugs

A. Jacquemin-Sablon, A. Papadaki-Valiraki, O. Todoulou, 1994, Archiv der Pharmazie.

Effect of membrane potential on the cellular uptake of 2-N-methyl-ellipticinium by L1210 cells.

A. Jacquemin-Sablon, J. Le Pecq, J. Charcosset, 1984, Biochemical pharmacology.

Effects of 9-OH-ellipticine on cell survival, macromolecular syntheses, and cell cycle progression in sensitive and resistant Chinese hamster lung cells.

A. Jacquemin-Sablon, J. Charcosset, M. Lantieri, 1985, Cancer research.

From the Modelization of DNA Platination to the Conception of New Drugs

E. Ségal-Bendirdjian, A. Jacquemin-Sablon, A. Yeung, 1991 .

Enzymatic breakage and joining of deoxyribonucleic acid. VI. Further purification and properties of polynucleotide ligase from Escherichia coli infected with bacteriophage T4.

A. Jacquemin-Sablon, C. Richardson, G. Fareed, 1968, The Journal of biological chemistry.

Cisplatin resistance in a murine leukemia cell line is associated with a defective apoptotic process.

E. Ségal-Bendirdjian, A. Jacquemin-Sablon, 1995, Experimental cell research.

Identification of new drug sensitivity genes using genetic suppressor elements: protein arginine N-methyltransferase mediates cell sensitivity to DNA-damaging agents.

L. Cavarec, A. Gudkov, A. Jacquemin-Sablon, 2003, Cancer research.

Influence of myc overexpression on the phenotypic properties of Chinese hamster lung cells resistant to antitumor agents.

A. Jacquemin-Sablon, F. Dautry, A. Larsen, 1991, Experimental cell research.

Multiple resistance mechanisms in Chinese hamster cells resistant to 9-hydroxyellipticine.

A. Jacquemin-Sablon, A. Larsen, 1989, Cancer research.

Bleomycin resistance in mammalian cells expressing a genetic suppressor element derived from the SRPK1 gene.

L. Mir, A. Jacquemin-Sablon, Guenhaël Sanz, 2002, Cancer research.

Selection of Genetic Suppressor Elements Conferring Resistance to DNA Topoisomerase II Inhibitors

L. Cavarec, A. Gudkov, A. Jacquemin-Sablon, 1999, Annals of the New York Academy of Sciences.

Induction of pgp3 expression and reversion of the multidrug resistance phenotype in 9-OH-ellipticine-resistant Chinese hamster lung fibroblasts transfected with the MYC oncogene.

A. Jacquemin-Sablon, F. Dautry, C. Delaporte, 1997, Biochemical pharmacology.

Unr, a cytoplasmic RNA-binding protein with cold-shock domains, is involved in control of apoptosis in ES and HuH7 cells

P. Lagarde, A. Jacquemin-Sablon, J. Markovits, 2007, Oncogene.

Regulation of Unr Expression by 5'- and 3'-Untranslated Regions of its mRNA through Modulation of Stability and IRES Mediated Translation

A. Jacquemin-Sablon, J. Markovits, H. Jacquemin-Sablon, 2005, RNA biology.

Yeast mitochondrial deoxyribonuclease stimulated by ethidium bromide. 2. Mechanism of enzyme activation.

A. Jacquemin-Sablon, C. Paoletti, M. Le Bret, 1979, Biochemistry.

Yeast mitochondrial deoxyribonuclease stimulated by ethidium bromide. III. Possible invovlement in the induction of "petite" mutation by phenanthridinium derivatives.

A. Jacquemin-Sablon, H. Jacquemin-Sablon, 1980, Mutation research.

Expression of the activated p185erbB2 tyrosine kinase in human epithelial cells leads to MAP kinase activation but does not confer oncogenicity.

A. Jacquemin-Sablon, J. Pierre, F. Nowak, 1997, Experimental cell research.

Lambda-repressed mutants of bacteriophage T5. I. Isolation and genetical characterization.

A. Jacquemin-Sablon, Y. Lanni, 1973, Virology.

Inhibitors in Chinese Hamster Cells Resistant to Topoisomerase II Reduced Formation of Protein-associated DNA Strand Breaks

K. Kohn, Y. Pommier, L. Zwelling, 2006 .

Cloning and characterization of full-length cDNAs coding for the DNA topoisomerase II beta from Chinese hamster lung cells sensitive and resistant 9-OH-ellipticine.

A. Jacquemin-Sablon, C. Delaporte, S. Dereuddre, 1995, Biochimica et Biophysica Acta.

Effects of 7H-pyridocarbazole mono and bifunctional DNA-intercalators on Chinese hamster lung cells in vitro.

B. Roques, A. Jacquemin-Sablon, C. Delaporte, 1984, Biochemical pharmacology.

Synthesis and biological activity of new dimers in the 7H-pyrido[4,3-c] carbazole antitumor series.

B. Roques, A. Jacquemin-Sablon, J. Le Pecq, 1992, Journal of medicinal chemistry.

Effects of tyrphostins on the activated c-src protein in NIH/3T3 cells.

A. Levitzki, A. Jacquemin-Sablon, J. Pierre, 1994, Molecular pharmacology.

Expression of topoisomerases II alpha and beta in Chinese hamster lung cells resistant to topoisomerase II inhibitors.

A. Jacquemin-Sablon, B. René, M. Casabianca-Pignede, 1994, Molecular pharmacology.

[Cytotoxicity and interaction of amsacrine derivatives with topoisomerase II: role of the 1' substitute on the aniline nucleus].

C. Bailly, A. Jacquemin-Sablon, P. Fossé, 1997, Bulletin du cancer.

Expression of drug sensitivity and tumorigenicity in intraspecies hybrids between 9-hydroxyellipticine-sensitive and -resistant cells.

A. Jacquemin-Sablon, J. Belehradek, J. Remy, 1984, Cancer research.

The 1'-substituent on the anilino ring of the antitumor drug amsacrine is a critical element for topoisomerase II inhibition and cytotoxicity.

C. Bailly, A. Jacquemin-Sablon, P. Fossé, 1996, Molecular pharmacology.

Characterization of prmt7alpha and beta isozymes from Chinese hamster cells sensitive and resistant to topoisomerase II inhibitors.

J. Bujnicki, A. Jacquemin-Sablon, L. Gros, 2006, Biochimica et biophysica acta.